Engels; Boris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engels; Boris.The latest application filed is for "chimeric antigen receptors and uses thereof".

Company Profile

11.7.23

Engels; Boris - Arlington MA
Engels; Boris - Cambridge MA
Engels; Boris - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Grant 11,413,340 - Brogdon , et al. August 16, 2	2022-08-16
Chimeric Antigen Receptors And Uses Thereof App 20210220404 - Abujoub; Aida ; et al.	2021-07-22
Cd19 And Cd22 Chimeric Antigen Receptors And Uses Thereof App 20210177900 - Engels; Boris ; et al.	2021-06-17
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Grant 11,026,976 - Brannetti , et al. June 8, 2	2021-06-08
Regulatable Chimeric Antigen Receptor App 20210087279 - Engels; Boris ; et al.	2021-03-25
Human Mesothelin Chimeric Antigen Receptors And Uses Thereof App 20200407460 - Beatty; Gregory ; et al.	2020-12-31
Targeting Cytotoxic Cells With Chimeric Receptors For Adoptive Immunotherapy App 20200377589 - Beatty; Gregory ; et al.	2020-12-03
Bcma-targeting Chimeric Antigen Receptor, And Uses Thereof App 20200371091 - Pruteanu-Malinici; Iulian ; et al.	2020-11-26
Human mesothelin chimeric antigen receptors and uses thereof Grant 10,640,569 - Beatty , et al.	2020-05-05
Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Comprising A Cd20 Binding Domain App 20200113941 - Brannetti; Barbara ; et al.	2020-04-16
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Grant 10,577,417 - Beatty , et al.	2020-03-03
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain Grant 10,525,083 - Brannetti , et al. J	2020-01-07
Treatment Of Cancer Using Chimeric T Cell Receptor Proteins Having Multiple Specificities App 20190375815 - Engels; Boris ; et al.	2019-12-12
Regulatable Chimeric Antigen Receptor App 20190263914 - Brogdon; Jennifer ; et al.	2019-08-29
Regulatable chimeric antigen receptor Grant 10,287,354 - Brogdon , et al.	2019-05-14
Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants Grant 10,189,908 - Schreiber , et al. Ja	2019-01-29
Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 Inhibitor For Combined Use In Anticancer Therapy App 20190000944 - Brogdon; Jennifer ; et al.	2019-01-03
Treatment Of Cancer Using Chimeric Antigen Receptors App 20180125892 - Brannetti; Barbara ; et al.	2018-05-10
Targeting Cytotoxic Cells With Chimeric Receptors For Adoptive Immunotherapy App 20170260268 - Beatty; Gregory ; et al.	2017-09-14
Chimeric Antigen Receptors Recognizing Cancer-Specific TN Glycopeptide Variants App 20170166652 - Schreiber; Hans ; et al.	2017-06-15
Chimeric Antigen Receptors Recognizing Cancer-specific Tn Glycopeptide Variants App 20170145108 - Schreiber; Hans ; et al.	2017-05-25
Regulatable Chimeric Antigen Receptor App 20170081411 - Engels; Boris ; et al.	2017-03-23
Human Mesothelin Chimeric Antigen Receptors And Uses Thereof App 20160311917 - Beatty; Gregory ; et al.	2016-10-27
Regulatable Chimeric Antigen Receptor App 20160311907 - Brogdon; Jennifer ; et al.	2016-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.